One example is the GLP‐1 homologue peptide exendin‐4 (Eng, Kleinman, Singh, Singh, & Raufman, 1992), in clinical use for type 2 diabetes treatment as exenatide. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.